Summit Therapeutics Inc. (NASDAQ: SMMT) seems poised for a price surge based on its latest charts. The company focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies. The company’s lead development candidate is Ivonescimab, a bispecific antibody for immunotherapy through the blockade of PD-1 with anti-angiogenesis.
Bullish Indications
#1 Breakout from Rising Wedge Pattern: As you can see from the daily chart, the stock had been forming a rising wedge pattern for the past few weeks. These are marked as purple color lines. The stock has currently broken out of the rising wedge pattern and has closed above the entire pattern with strong bullish volume. This indicates that the bulls are in control and the price is unlikely to decrease.
SMMT – Daily Chart
#2 Price above MAs: The price is currently above the short-term moving average of 50-day SMA as well as the longer-term moving average of 200-day SMA, indicating that the bulls are still in control. This is a positive indication.
#3 Bullish ADX: The ADX indicator shows that the +DI line is currently above the –DI line and the ADX line has started to move up from below the –DI and +DI lines. This indicates possible bullishness.
#4 Bullish Aroon: The value of Aroon Up (orange line) is above 70 while Aroon Down (blue line) is below 30 in the daily chart. This indicates possible bullishness.
#5 Above Support Area: As you can see from the weekly chart, the stock has currently moved up from a resistance-turned-support level. This level is marked as a pink color dotted line. This looks like a good area for the stock to move higher. The stock is also trading above its 50-week and 200-week SMA, indicating that the bulls are still in control.
SMMT – Weekly Chart
#6 %K above %D: The %K (blue) line of stochastic has currently crossed above the %D (Orange) line in the weekly chart. This is a possible bullish indication.
#7 Bullish MACD: The MACD line is above the MACD signal line in the weekly chart, indicating bullishness.
Recommended Trade (based on the charts)
Buy Levels: If you want to get in on this trade, you can purchase shares of SMMT above the price of around $20.00.
TP: Our target prices are $25 and $30 in the next 3-6 months.
SL: To limit risk, place stop-loss at $16.80. Note that the stop-loss is on a closing basis.
Our target potential upside is 25% to 50% in the next 3 to 6 months.
For a risk of $3.20, our target rewards are $5.00 and $10.00. This is a nearly 1:2 and 1:3 risk-reward trade.
In other words, this trade offers nearly 2x to 3x more potential upside than downside.
Risks to Consider
The stock may reverse its overall trend if it breaks down from the rising wedge pattern with a high volume. The sell-off of the stock could also be triggered in case of any negative news, overall weakness in the market, or any regulatory changes in the sector.
Happy Trading!
Tara
The Next Nvidia? [sponsor]Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet... but in the next 6 months that's all they'll talk about. Go here now for this breaking story.